Ni Putu Sriwidyani, I Wayan Juli Sumadi


Introduction: Death in breast cancer patients are mostly caused by the presence of distant metastasis and nodal status is the strongest prognostic factor of metastasis. CD8+ T lymphocyte/tumor budding index is a representation of the anti/protumor properties interaction. The purpose of this study is to prove the interaction between tumor cells and tumor microenvironment and its relationship nodal status in breast carcinoma. Methods: A cross sectional analytic study using 45 cases of breast carcinoma which were underwent mastectomy and radical axillary lymph node dissection at Sanglah Hospital Denpasar during 1 January until 31 December 2017 was conducted. Tumor budding was a small group of cells at the edge of tumor invasion which was evaluated at H-E slide. CD8+ T lymphocyte was evaluated on immunohistochemical slide and was calculated on the peritumoral stroma. Results: Using ROC curve, cut-off value was 4.05. Of all cases, 23 cases with low and 22 cases with high CD8+ T lymphocyte/tumor budding index. CD8+ T lymphocyte/tumor budding index had a significant inverse correlation with nodal status (p=0.000), meanwhile LVI has linier correlation with nodal status in breast carcinoma (p=0.006). Conclusion: there was an inverse relationship between CD8+ T lymphocyte/tumor budding index with nodal status in patients with breast carcinoma

Full Text:



Liang F, Cao W, Wang Y, Li L, Zhang G, Wang Z (2013). The prognostic value of tumor budding in invasive breast cancer. Pathology, research and practice. 209(5):269-75.

Salhia B, Trippel M, Pfaltz K, Cihoric N, Grogg A, Ladrach C, Zlobec I, Tapia C (2015). High tumor budding stratifies breast cancer with metastatic properties. Breast cancer research and treatment. 150(2):363-71.

Gujam FJ, McMillan DC, Mohammed ZM, Edwards J, Going JJ (2015). The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer. British journal of cancer. 113(7):1066-74.

Sriwidyani NP, Alit-Artha IG, Mantik-Astawa IN, Manuaba IBTW (2016). Tumor budding in breast carcinoma: relation to E-Cadherin, MMP-9 expression, and metastasis risk. Bali Med J. 5(3):497-501.

Prall F (2007). Tumour budding in colorectal carcinoma. Histopathology. 50(1):151-62.

Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR (2011). Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(15):1949-55.

Ali HR, Provenzano E, Dawson SJ, Blows FM, Liu B, Shah M, Earl HM, Poole CJ, Hiller L, Dunn JA, Bowden SJ, Twelves C, Bartlett JM, Mahmoud SM, Rakha E, Ellis IO, Liu S, Gao D, Nielsen TO, Pharoah PD, Caldas C (2014). Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. Annals of oncology : official journal of the European Society for Medical Oncology. 25(8):1536-43.

Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ, Panel m (2005). Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Annals of oncology : official journal of the European Society for Medical Oncology. 16(10):1569-83.

Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ, Panel m (2013). Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Annals of oncology : official journal of the European Society for Medical Oncology. 24(9):2206-23.

Goker M, Devoogdt N, Van de Putte G, Schobbens JC, Vlasselaer J, Van den Broecke R, de Jonge ET (2013). Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance. Facts, views & vision in ObGyn. 5(2):106-15.

Goyal A, Duley L, Fakis A (2013). Axillary treatment for patients with early breast cancer and lymph node metastasis: systematic review protocol. World journal of surgical oncology. 11:6.

Lugli A, Karamitopoulou E, Panayiotides I, Karakitsos P, Rallis G, Peros G, Iezzi G, Spagnoli G, Bihl M, Terracciano L, Zlobec I (2009). CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. British journal of cancer. 101(8):1382-92.

Youlden DR, Cramb SM, Yip CH, Baade PD (2014). Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer biology & medicine. 11(2):101-15.


  • There are currently no refbacks.